Trial Profile
Phase II Study of Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Gimeracil/oteracil/tegafur
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- 03 Sep 2014 New trial record